# US 2025/0084414 A1 · Nonviral vectors for gene therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084414 A1
- Document ID: US20250084414A1
- Status: Published application
- Kind: A1
- Application number: 18/845,379
- Filed: 2023-03-06
- Published: 2025-03-13
- Earliest claimed: 2022-03-09
- Applicants: Politecnico Di Milano; Fondazione Irccs Istituto Neurologico Carlo Besta
- Inventors: Francesca BALDELLI; Pierangelo METRANGOLO; Gabriella CAVALLO; Nina BONO; Gabriele CANDIANI; Marta ROSATI; Giuseppe PINTER LAURIA; Stefania MARCUZZO
- Web page: https://patentgrep.com/patent/US20250084414A1

## CPC

- C07D 249/04: 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- A61K 48/005: {characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C08G 83/002: {Dendritic macromolecules}
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/351: Conjugate
- C12N 2320/32: Special delivery means, e.g. tissue-specific
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present invention relates to fluorinated amphiphilic dendrimer structures (FJDs) capable of self-assembling into supramolecular systems of different size and shape. A further object is a supramolecular complex comprising at least one of the dendrimer structures according to the present invention and the use thereof in gene therapy.

## Claims

### Claim 1

Fluorinated dendrimeric structure of Formula (I)
Wherein
n is an integer between 1 and 5;
R is selected from
R1 is selected from
X is selected independently from:
OH; (6)
COOH (7)
NH2 (8)
NH3+Y− (9)
NR22 (10)
NR23+Y− (11)
Wherein
R2 is selected independently from —CH3, —CH2CH3, —CH2CH2CH3, —CH(CH3)2, —CH2OH, —CH2CH2OH;
Y− is selected from:

### Claim 2 (depends on 1)

The structure according to claim 1, wherein n is 2 or 3.

### Claim 3 (depends on 1)

The structure according to claim 1, wherein R is

### Claim 4 (depends on 1)

The structure according to claim 1, wherein R1 is

### Claim 5 (depends on 1)

The structure according to claim 1, wherein X=NH3+Y− and Y is selected from 6.

### Claim 6 (depends on 1)

The structure according to claim 1, wherein n=3, R is (2), R1 is (5), X=NH3+Y−, Y is (12) and it is FDG2N.

### Claim 7 (depends on 1)

A supramolecular complex comprising at least one of the dendrimeric structures according to claim 1 and one or more nucleic acids.

### Claim 8 (depends on 7)

The complex according to claim 7, wherein the ratio between the nitrogen atoms of said dendrimeric structure and the phosphorus atoms of said one or more nucleic acids (N/P) is comprised between 5 and 40.

### Claim 9 (depends on 7)

The complex according to claim 7, wherein N/P=30.

### Claim 10 (depends on 7)

A supramolecular complex according to claim 7, for use in gene therapy.
